These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12593941)

  • 41. Can compression induce demixing in amorphous solid dispersions? A case study of naproxen-PVP K25.
    Ayenew Z; Paudel A; Van den Mooter G
    Eur J Pharm Biopharm; 2012 May; 81(1):207-13. PubMed ID: 22293573
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances.
    Srivalli KM; Mishra B
    AAPS PharmSciTech; 2016 Apr; 17(2):272-83. PubMed ID: 26077622
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Investigation and physicochemical characterization of vinpocetine-sulfobutyl ether beta-cyclodextrin binary and ternary complexes.
    Ribeiro L; Loftsson T; Ferreira D; Veiga F
    Chem Pharm Bull (Tokyo); 2003 Aug; 51(8):914-22. PubMed ID: 12913228
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of excipients on solubility and dissolution of pharmaceuticals.
    Paus R; Prudic A; Ji Y
    Int J Pharm; 2015 May; 485(1-2):277-87. PubMed ID: 25749073
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structural evaluation of crystalline ternary γ-cyclodextrin complex.
    Higashi K; Ideura S; Waraya H; Moribe K; Yamamoto K
    J Pharm Sci; 2011 Jan; 100(1):325-33. PubMed ID: 20665507
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interaction of naproxen with alpha-cyclodextrin and its noncyclic analog maltohexaose.
    Bettinetti G; Sorrenti M; Negri A; Setti M; Mura P; Melani F
    Pharm Res; 1999 May; 16(5):689-94. PubMed ID: 10350012
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diffusion of naproxen in presence of beta-cyclodextrin across a silicone rubber membrane.
    Orienti I; Fini A; Zecchi V; Zuman P
    Pharm Acta Helv; 1991; 66(7):204-8. PubMed ID: 1763095
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bupivacaine hydrochloride complexation with some alpha- and beta-cyclodextrins studied by potentiometry with membrane electrodes.
    Kopecký F; Vojteková M; Kaclík P; Demko M; Bieliková Z
    J Pharm Pharmacol; 2004 May; 56(5):581-7. PubMed ID: 15142334
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of the complexation of diflunisal with hydroxypropyl-beta-cyclodextrin.
    Ugwu SO; Alcala MJ; Bhardwaj R; Blanchard J
    J Pharm Biomed Anal; 1999 Mar; 19(3-4):391-7. PubMed ID: 10704104
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enhancement of carvedilol solubility by solid dispersion technique using cyclodextrins, water soluble polymers and hydroxyl acid.
    Yuvaraja K; Khanam J
    J Pharm Biomed Anal; 2014 Aug; 96():10-20. PubMed ID: 24705456
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lumichrome complexation by cyclodextrins: influence of pharmaceutical excipients.
    Lilletvedt M; Kristensen S; Tønnesen HH
    Pharmazie; 2010 Dec; 65(12):871-6. PubMed ID: 21284255
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Orthogonal experimental preparation of Sanguis Draconis- Polyvinylpyrrolidone microfibers by electrospinning.
    Huang L; Cao K; Hu P; Liu Y
    J Biomater Sci Polym Ed; 2019 Mar; 30(4):308-321. PubMed ID: 30686124
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of hydroxypropyl-beta-cyclodextrin on hydrocortisone dissolution from films intended for ocular drug delivery.
    Bećirević-Laćan M; Filipović-Grcić J
    Pharmazie; 2000 Jul; 55(7):518-20. PubMed ID: 10944780
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of polymer molecular weight on the production of drug nanoparticles.
    Sepassi S; Goodwin DJ; Drake AF; Holland S; Leonard G; Martini L; Lawrence MJ
    J Pharm Sci; 2007 Oct; 96(10):2655-66. PubMed ID: 17696165
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cryomilling-induced solid dispersion of poor glass forming/poorly water-soluble mefenamic acid with polyvinylpyrrolidone K12.
    Kang N; Lee J; Choi JN; Mao C; Lee EH
    Drug Dev Ind Pharm; 2015 Jun; 41(6):978-88. PubMed ID: 24849785
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Valproic acid-hydrophilic cyclodextrin complexes and valproic acid-solid dispersions: evaluation of their potential pharmaceutical use.
    Trapani G; Cutrignelli A; Latrofa A; Franco M; Serra M; Pisu MG; Biggio G; Liso G
    Drug Dev Ind Pharm; 2004 Jan; 30(1):53-64. PubMed ID: 15000430
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fluorometric studies on inclusion complexation of L/D-tryptophan by beta-cyclodextrin 6-O-pyridinecarboxylates.
    Liu Y; Li B; Wada T; Inoue Y
    Bioorg Chem; 2001 Feb; 29(1):19-26. PubMed ID: 11300692
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rofecoxib-beta-cyclodextrin inclusion complex for solubility enhancement.
    Rawat S; Jain SK
    Pharmazie; 2003 Sep; 58(9):639-41. PubMed ID: 14531460
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Daidzein/cyclodextrin/hydrophilic polymer ternary systems.
    Borghetti GS; Pinto AP; Lula IS; Sinisterra RD; Teixeira HF; Bassani VL
    Drug Dev Ind Pharm; 2011 Aug; 37(8):886-93. PubMed ID: 21247375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.